Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Completed

Scaling CRC Screening Through Outreach, Referral, and Engagement (SCORE)

Scaling Colorectal Cancer Screening Through Outreach, Referral, and Engagement (SCORE): A State-Level Program to Reduce Colorectal Cancer Burden in Vulnerable Populations

Outcome
Results posted; no analysis attached
Phase
No phase (not a drug trial)
Status
Completed
Study type
Interventional
Start
7 July 2020
Ended
2 September 2024
Enrollment
4,318 participants
Sites
2
Primary outcomes
Proportion of Subjects Who Completed Colorectal Cancer (CRC) Screening Within 6 Months (Trial - Age Group 50-75)
Sponsor type
Academic / other
Results posted
25 June 2024
Last update
15 May 2026

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Results

Primary endpoint
Results posted; no analysis attachedAs posted on ClinicalTrials.gov ↗, registry record of 15 May 2026
Primary outcome
Proportion of Subjects Who Completed Colorectal Cancer (CRC) Screening Within 6 Months (Trial - Age Group 50-75)Trial Mailed FIT Intervention - Age Group 50-75: 598 of 2001Trial Usual Care - Age Group 50-75: 192 of 2001Values: ParticipantsTime frame: Up to 6 months after randomizationNo analysis posted for this outcome (outcome 1)
Participants
Experimental: Trial Mailed FIT - Age Group 50-75: 2001 started, 2001 completedNo Intervention: Trial Usual Care - Age Group 50-75: 2001 started, 2001 completedExperimental: Sub-study Mailed FIT Age Group 45-49 Enhanced Envelope: 158 started, 158 completedActive Comparator: Sub-study Mailed FIT Comparator Plain Envelope - Age Group 45-49: 158 started, 158 completed
Serious adverse events
Experimental: Trial Mailed FIT - Age Group 50-75: 0 of 0No Intervention: Trial Usual Care - Age Group 50-75: 0 of 0Experimental: Sub-study Mailed FIT Age Group 45-49 Enhanced Envelope: 0 of 0Active Comparator: Sub-study Mailed FIT Comparator Plain Envelope - Age Group 45-49: 0 of 0Participants with at least one serious adverse event, of those at risk, as posted
10 secondary outcomes, the first 8 shown
Proportion of Subjects Who Returned a Completed Mailed FIT at 60 Days
Trial Mailed FIT Intervention - Age Gro… 409/2001 [Participants]
Proportion of Subjects Who Completed a Follow-up (Diagnostic) Colonoscopy
Abnormal FIT: Trial Mailed FIT Intervention - Age Gro… 48/81; Trial Usual Care - Age Group 50-75 18/26 [Participants] (first of 2 rows)
Number of Subject Colorectal Carcinoma (CRC) and Advanced Adenomas Detected at 12 Months
Trial Mailed FIT Intervention - Age Gro… 22/598; Trial Usual Care - Age Group 50-75 8/192 [Participants]
Number of Days From CRC Diagnosis to the Date of Evaluation for CRC Treatment
Trial Mailed FIT Intervention - Age Gro… 3.25 (0 to 13), n=5; Trial Usual Care - Age Group 50-75 0 (0 to 0), n=2 [mean days, Full Range]
Number of Subjects Who Received Referral for Cancer Treatment
Trial Mailed FIT Intervention - Age Gro… 4/5; Trial Usual Care - Age Group 50-75 2/2 [Participants]
Number of Subjects Mailed FITs Completed After Two Rounds of Annual FIT Outreach
Completed 0 Annual FITs 1372/2001; Completed 1 Annual FIT Screening Only i… 261/2001; Completed 1 Annual FIT Screening Only i… 116/1624; Completed 2 Annual FIT Screenings in Ye… 252/1624 [Participants]
The Proportion of Subjects, Ages 45-49, Who Are Current With CRC Screening
Screening-eligible population, aged 45-49 years o…: Experimental: Mailed FIT Intervention E… 158/158; Active Comparator: Sub-study Mailed FIT… 158/158 [Participants] (first of 2 rows)
Proportion of Subjects, Ages 45-49, Who Completed Mailed FIT at 60 Days
Trial Mailed FIT Intervention - Age Gro… 34/158; Trial Usual Care - Age Group 45-49 20/158 [Participants]

Every value is copied from the trial’s results record at ClinicalTrials.gov. “Statistically significant” describes the posted test only: it does not say which group did better, and nothing here is read from a paper.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

This study will test the effectiveness of mailing fecal immunochemical tests (FITs) in increasing colorectal cancer (CRC) screening rates in U.S. adults ages 45-75. We are implementing this study in two age groups, 45-49 years and 50-75 years.

Detailed description public domain (ClinicalTrials.gov)

Trial (Age Group 50-75) This randomized controlled trial assesses the effectiveness, feasibility, acceptability, and cost-effectiveness of mailing FITs from a central location to patients served by FQHCs. Subjects are randomly selected and assigned to receive either a mailed FIT intervention (Arm 1: Trial Mailed FIT Intervention - Age Group 50-75) or usual care (Arm 2: Trial Usual Care - Age Group 50-75). To assess United States Preventive Services Task Force recommendations for annual screening, we will mail subjects one round of FIT per year for up to two years. Sub-study (Age Group 45-49) A sub-study assesses the effectiveness of mailing FITs from a central location to patients who are 45-49 years of age and newly eligible for CRC screening. The sub-study also assesses the impact of varying the appearance of the FIT packet mailing envelope on FIT return. All eligible patients from one FQHC clinic site are randomly assigned to receive either a mailed FIT intervention that includes an enhanced mailing envelope (Arm 3: Sub-study Mailed FIT Intervention Enhanced Envelope - Age Group 45-49) or a plain envelope (Arm 4: Sub-study Mailed FIT Active Comparator Plain Envelope - Age Group 45-49). The Trial (Age Group 50-75) and the Sub-study (Age Group 45-49) also assess the effectiveness of delivering patient navigation from a central location to facilitate follow up colonoscopy for patients with a positive (abnormal) FIT result.

Posted results (ClinicalTrials.gov registry) · primary outcome public domain (ClinicalTrials.gov)

Proportion of Subjects Who Completed Colorectal Cancer (CRC) Screening Within 6 Months (Trial - Age Group 50-75) [Up to 6 months after randomization]. Count Of Participants, Participants. Trial Mailed FIT Intervention - Age Group 50-75 (n=2001): 598; Trial Usual Care - Age Group 50-75 (n=2001): 192.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Proportion of Subjects Who Returned a Completed Mailed FIT at 60 Days [Up to 60 days after randomization]. Count Of Participants, Participants. Trial Mailed FIT Intervention - Age Group 50-75 (n=2001): 409.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Proportion of Subjects Who Completed a Follow-up (Diagnostic) Colonoscopy [Up to 6 months after diagnostic colonoscopy referral date]. Count Of Participants, Participants. Abnormal FIT: Trial Mailed FIT Intervention - Age Group 50-75 (n=81): 48; Trial Usual Care - Age Group 50-75 (n=26): 18. Completed colonoscopy: Trial Mailed FIT Intervention - Age Group 50-75 (n=81): 33; Trial Usual Care - Age Group 50-75 (n=26): 8.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Number of Subject Colorectal Carcinoma (CRC) and Advanced Adenomas Detected at 12 Months [Up to 12 months after screening or diagnostic colonoscopy result date]. Count Of Participants, Participants. Trial Mailed FIT Intervention - Age Group 50-75 (n=598): 22; Trial Usual Care - Age Group 50-75 (n=192): 8.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Number of Days From CRC Diagnosis to the Date of Evaluation for CRC Treatment [Up to 12 months after CRC diagnosis]. Mean, days (Full Range). Trial Mailed FIT Intervention - Age Group 50-75 (n=5): 3.25 (0 to 13); Trial Usual Care - Age Group 50-75 (n=2): 0 (0 to 0).

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Number of Subjects Who Received Referral for Cancer Treatment [Up to 6 months after cancer diagnosis date]. Count Of Participants, Participants. Trial Mailed FIT Intervention - Age Group 50-75 (n=5): 4; Trial Usual Care - Age Group 50-75 (n=2): 2.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Number of Subjects Mailed FITs Completed After Two Rounds of Annual FIT Outreach [Round 1 time frame: at 6 months after randomization; Round 2 time frame: at 6 months after determining eligibility for Round 2]. Count Of Participants, Participants. Completed 0 Annual FITs (n=2001): 1372; Completed 1 Annual FIT Screening Only in Year 1 (n=2001): 261; Completed 1 Annual FIT Screening Only in Year 2 (n=1624): 116; Completed 2 Annual FIT Screenings in Year 1 and Year 2 (n=1624): 252.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

The Proportion of Subjects, Ages 45-49, Who Are Current With CRC Screening [Up to 6 months after randomization]. Count Of Participants, Participants. Screening-eligible population, aged 45-49 years old: Experimental: Mailed FIT Intervention Enhanced Envelope - Age Group 45-49 Enhanced Envelope (n=158): 158; Active Comparator: Sub-study Mailed FIT Comparator Plain Envelope - Age Group 45-49 (n=158): 158. Count of screened participants: Experimental: Mailed FIT Intervention Enhanced Envelope - Age Group 45-49 Enhanced Envelope (n=158): 53; Active Comparator: Sub-study Mailed FIT Comparator Plain Envelope - Age Group 45-49 (n=158): 45.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Proportion of Subjects, Ages 45-49, Who Completed Mailed FIT at 60 Days [60 days after randomization]. Count Of Participants, Participants. Trial Mailed FIT Intervention - Age Group 45-49 (n=158): 34; Trial Usual Care - Age Group 45-49 (n=158): 20.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Proportion of Subjects Who Completed a Follow up (Diagnostic) Colonoscopy [Up to 6 months after abnormal FIT result date]. Count Of Participants, Participants. positive (abnormal) FIT/FOBT result: Trial Mailed FIT Intervention - Age Group 45-49 (n=158): 2; Trial Usual Care - Age Group 45-49 (n=158): 1. completed a follow-up colonoscopy: Trial Mailed FIT Intervention - Age Group 45-49 (n=158): 2; Trial Usual Care - Age Group 45-49 (n=158): 1.